10.6084/m9.figshare.c.3697129_D4.v1 Jessica Bauer Jessica Bauer Ozkan Ozden Ozkan Ozden Naomi Akagi Naomi Akagi Timothy Carroll Timothy Carroll Daniel Principe Daniel Principe Jonas Staudacher Jonas Staudacher Martina Spehlmann Martina Spehlmann Lars Eckmann Lars Eckmann Paul Grippo Paul Grippo Barbara Jung Barbara Jung Additional file 2: Figure S1. of Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer Springer Nature 2015 Colon cancer Activin TGFβ PI3K Mitogenic signaling p21 2015-10-24 05:00:00 Figure https://springernature.figshare.com/articles/figure/Additional_file_2_Figure_S1_of_Activin_and_TGF_use_diverging_mitogenic_signaling_in_advanced_colon_cancer/4672339 ACVR2 interacts with p85 after activin treatment. FET cells were used for co-immunoprecipitation with ACVR2, TGFBR1 or TGFBR2 and Western blotted with p85.  There is an induction of ACVR2/p85 association following activin treatment, however, the increase in ACVR1/p85 association was more pronounced.  Neither TGFBR1 nor TGFBR2 directly associated with p85 following ligand stimulation. (EPS 3051 kb)